Prescriptions for children ages 8 to 11 with obesity jumped more than 300-fold since 2019, according to researchers at New York University. The FDA has not approved GLP-1 drugs for children under 12, but doctors prescribe them off-label for extreme cases. There are no long-term pediatric safety data on the […]
The post GLP-1 Weight-Loss Drug Prescriptions for Young Kids Skyrocketing, Study Finds appeared first on Activist Post.
